Treatment and prognosis of massive hemoptysis in cystic fibrosis.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications* / Q000628:therapy; D004322:Drainage; D005260:Female; D006469:Hemoptysis / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008297:Male; D009820:Ohio; D026741:Physical Therapy Modalities; D011379:Prognosis; D012008:Recurrence; D014812:Vitamin K / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014812:Vitamin K